{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:19:30Z","timestamp":1790813970379,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>De novo donor-specific antibodies (DSAs) are associated with antibody-mediated rejection (AMR) and allograft loss. Whether monitoring of de novo DSA (dnDSA) paired with systematic kidney biopsy should become routine remains to be established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>A retrospective multicentric study (9 French kidney transplant units of the Spiesser group) included patients without graft dysfunction biopsied because of the presence of dnDSA (One Lambda, mean fluorescence intensity [MFI], &gt;1000).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>One hundred twenty-three patients (85 male\/38 female; mean age, 49.5 \u00b1 13.1 y old) were biopsied after the detection of a dnDSA, 65.3 months (median) after kidney transplantation. Graft function was stable within 3 months before biopsy (estimated glomerular filtration rate, 55.3 \u00b1 18.9 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>). Fifty-one subclinical AMRs (sAMRs) (41.4%) were diagnosed, of which 32 (26%) active and 19 (15.5%) chronic active sAMR. Seventy-two biopsies revealed no AMR (58.5%). Predictive factors associated with the diagnosis of active sAMR were MFI of immunodominant DSA &gt;4000, MFI of the sum of DSA &gt;6300, age of the recipient &lt;45 years old, and the absence of steroids at biopsy. The presence of proteinuria &gt;200 mg\/g was predictive of chronic active sAMR. The decrease of estimated glomerular filtration rate at 5 years post-biopsy was significantly higher in patients with acute sAMR (\u221225.2 \u00b1 28.3 mL\/min\/1.73 m<jats:sup>2<\/jats:sup>) and graft survival significantly lower.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Performing a kidney graft biopsy for the occurrence of dnDSA without renal dysfunction leads to the diagnosis of a sAMR in over 40% of cases. Nevertheless, we did not observe any effect of standard treatment in acute sAMR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003055","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T16:19:59Z","timestamp":1575908399000},"page":"1726-1737","source":"Crossref","is-referenced-by-count":34,"title":["Protocol Biopsies in Patients With Subclinical De Novo Donor-specific Antibodies After Kidney Transplantation: A Multicentric Study"],"prefix":"10.1097","volume":"104","author":[{"given":"Dominique","family":"Bertrand","sequence":"first","affiliation":[{"name":"Nephrology Kidney Transplantation Dialysis, CHU Rouen, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gatault","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Tours, Tours, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eft\u00e9","family":"Jaur\u00e9guy","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Amiens, Amiens, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Garrouste","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Clermont Ferrand, Clermont Ferrand, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Sayegh","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Angers, Angers, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bouvier","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Caen, Caen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Strasbourg, Strasbourg, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lanfranco","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Brest, Brest, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali\u00e9nor","family":"Galinier","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation, CHU Poitiers, Poitiers, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laurent","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation Dialysis, CHU Rouen, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Etienne","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation Dialysis, CHU Rouen, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Farce","sequence":"additional","affiliation":[{"name":"EFS Normandie, EFS Normandie, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"Pathology, CHU Rouen, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[{"name":"Nephrology Kidney Transplantation Dialysis, CHU Rouen, Rouen, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence.","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-6143.2011.03926.x","article-title":"Banff 2011 meeting report: New concepts in antibody-mediated rejection.","volume":"12","author":"Mengel","year":"2012","journal-title":"Am J Transplant"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients.","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1056\/NEJMra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts.","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1111\/j.1600-6143.2009.02813.x","article-title":"Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies.","volume":"9","author":"Loupy","year":"2009","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts.","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/TP.0000000000002566","article-title":"Subclinical antibody-mediated rejection after kidney transplantation: Treatment outcomes.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group.","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1600-6143.2012.04325.x","article-title":"Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies.","volume":"13","author":"de Kort","year":"2013","journal-title":"Am J Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/TP.0000000000001012","article-title":"De novo anti-HLA DSA characteristics and subclinical antibody-mediated kidney allograft injury.","volume":"100","author":"Yamamoto","year":"2016","journal-title":"Transplantation"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/ajt.14161","article-title":"The value of protocol biopsies to identify patients with de novo donor-specific antibody at high risk for allograft loss.","volume":"17","author":"Schinstock","year":"2017","journal-title":"Am J Transplant"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/ajt.14466","article-title":"Utility of protocol kidney biopsies for de novo donor-specific antibodies.","volume":"17","author":"Parajuli","year":"2017","journal-title":"Am J Transplant"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.14015","article-title":"Evaluation of C1Q status and titer of de novo donor-specific antibodies as predictors of allograft survival.","volume":"17","author":"Wiebe","year":"2017","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival.","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of c3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"Igg donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury.","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/tri.13395","article-title":"Factors at de novo donor-specific antibody initial detection associated with allograft loss: A multicenter study.","volume":"32","author":"Schinstock","year":"2019","journal-title":"Transpl Int"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajt.14584","article-title":"Antibody-mediated rejection: New approaches in prevention and management.","volume":"18","author":"Montgomery","year":"2018","journal-title":"Am J Transplant"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2017070749","article-title":"Dynamic prognostic score to predict kidney allograft survival in patients with antibody-mediated rejection.","volume":"29","author":"Viglietti","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000225783.86950.c2","article-title":"Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.","volume":"82","author":"Kee","year":"2006","journal-title":"Transplantation"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1600-6143.2006.01436.x","article-title":"The significance of subclinical rejection and the value of protocol biopsies.","volume":"6","author":"Nankivell","year":"2006","journal-title":"Am J Transplant"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1056\/NEJMc1813976","article-title":"Antibody-mediated rejection of solid-organ allografts.","volume":"379","author":"Cruzado","year":"2018","journal-title":"N Engl J Med"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"e0178572","DOI":"10.1371\/journal.pone.0178572","article-title":"Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.","volume":"12","author":"Matignon","year":"2017","journal-title":"Plos One"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1681\/ASN.2017010004","article-title":"Precision transplant medicine: Biomarkers to the rescue.","volume":"29","author":"Naesens","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/ajt.15055","article-title":"Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.","volume":"19","author":"Luque","year":"2019","journal-title":"Am J Transplant"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1111\/ajt.12462","article-title":"Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.","volume":"13","author":"Reed","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:23:58Z","timestamp":1696224238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003055","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11,26]]}}}